Nanotechnology News

RSS

Major Project to Investigate Safety of Nanoparticles in Facade Paint

Five Empa laboratories were involved in the EU «NanoHouse» project, along with four other European research institutes and four industrial partners. The aim of the project was to investigate the opportunities and risks presented by the nanomaterials used in the surface coatings applied to building façades. For the first time not only were freshly manufactured products studied to see if they set free nanoparticles, but also aged samples.

16 Jan 2014

3D nanoSIMS Project to Develop Label-Free Molecular Imaging for Measuring Intracellular Drug Distribution

3D nanoSIMS project will provide high-resolution label-free imaging to reliably see where drugs go to in cells for the first time.

16 Jan 2014

ERC Awards Consolidator Grant to imec Researcher for SCALPEL Project

Imec, a world leading nanoelectronics research center, proudly announces that Prof. Dr. Liesbet Lagae, R&D Manager Life Science Technologies at imec and professor in Nanobio Physics at KU Leuven, has been awarded a Consolidator Grant for her research project SCALPEL by the European Research Council (ERC).

From IMEC 16 Jan 2014

SEMICON Korea: QuantumClean and ChemTrace to Exhibit at the 2014 Tradeshow

QuantumClean® and ChemTrace® today announced that they will be exhibiting at the SEMICON Korea tradeshow, held at the Coex in Seoul, South Korea from February 12th through February 14th, 2014.

15 Jan 2014

NantBioScience to License Nanoparticle Albumin-Bound Technology from Celgene

NantBioScience, subsidiary of NantWorks, LLC, a company focused on the discovery and development of innovative treatments for diseases with high unmet medical needs, today announced a strategic collaboration with Celgene to advance bold research programs to benefit cancer patients in need of new therapeutic solutions. As part of the transaction, Celgene will pay $75 million in funding to NantBioScience as an upfront option fee and equity investment.

15 Jan 2014

Fabrus Acquires Worldwide Rights to Chimerasome Nanocage Technology

Fabrus, Inc., a San Diego based antibody discovery company, announced today that it has obtained worldwide exclusive rights to Chimerasome™ nanocage technology originally developed by Chimeros, Inc.

15 Jan 2014

Novavax Continues Partnership with PATH to Develop RSV Vaccine for Maternal Immunization

Novavax, Inc. announced the continuation of their partnership with PATH to develop Novavax' RSV (respiratory syncytial virus) vaccine for maternal immunization. Under this amendment, PATH will provide Novavax approximately $3.5 million in funding to support the ongoing Phase II dose-confirmatory clinical trial in women of childbearing age, initiated in October 2013. Under this partnership, Novavax and PATH will also initiate planning activities for clinical development of the vaccine in low-resource countries.

From Novavax Inc. 15 Jan 2014

RBCC-n3D Assay System Utilizes Biocompatible Magnetic Nanoparticles to Print Cells Into 3D Structures

Rainbow Coral Corp.’s joint venture partner, Nano3D Biosciences (n3D), has developed the first commercially available 3D bioprinting system designed for high throughput and high-content drug screening, and the global market potential for the device points to very bright future for the company.

15 Jan 2014

New Market Report on Functional Materials for Future Electronics

Research and Markets has announced the addition of the "Functional Materials for Future Electronics: Metals, Inorganic & Organic Compounds, Graphene, CNT" report to their offering.

From Research and Markets 15 Jan 2014

Cerulean’s CRLX101 Nanopharmaceutical Phase 2 Clinical Trial Achieves Primary Endpoint

Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced that CRLX101 has achieved its primary efficacy endpoint in an ongoing single-arm Phase 2 monotherapy clinical trial in relapsed ovarian cancer.

From Cerulean Pharma 15 Jan 2014

CWRU Receives $540,000 Federal Grant to Devise Methods for Building Nanostructures

Researchers at Case Western Reserve University have received a $540,000 federal grant to devise methods for building minute structures tailored to precisely deliver medicines to tumors or carry dyes that help imaging technologies detect disease, create more efficient nanowires and nanoelectonics, and more.

15 Jan 2014

Forecast Report on Next-Generation Quantum Dot and Quantum Dot Display LED Market

Quantum Dot and Quantum Dot Display (QLED) Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019 2013 study has 221 pages, 80 tables and figures. Quantum dots will cascade into the marketplace. They offer lower cost, longer life, and brighter lighting.

15 Jan 2014

Versatile Switchable Nanoparticles Detect Medical Conditions

A world of cloak-and-dagger pharmaceuticals has come a step closer with the development of stealth compounds programmed to spring into action when they receive the signal.

15 Jan 2014

JPK NanoTracker™ Optical Tweezers Used for Biomacromolecule Research at NTNU, Trondheim

JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on how the NanoTracker™ Optical Tweezers system is being applied in the study of biomacromolecules at NTNU in Trondheim.

From Bruker BioAFM 14 Jan 2014

Wyatt to Showcase Macromolecular Characterization Expertise in WCBP Seminar and Poster

Wyatt Technology Corporation, the world leader in absolute macromolecular characterization instrumentation and software, will be presenting on innovative light scattering techniques at WCBP 2014, Washington, DC, January ...

From Waters | Wyatt Technology 13 Jan 2014

Nanotechnology News

Major Project to Investigate Safety of Nanoparticles in Facade Paint

3D nanoSIMS Project to Develop Label-Free Molecular Imaging for Measuring Intracellular Drug Distribution

ERC Awards Consolidator Grant to imec Researcher for SCALPEL Project

SEMICON Korea: QuantumClean and ChemTrace to Exhibit at the 2014 Tradeshow

NantBioScience to License Nanoparticle Albumin-Bound Technology from Celgene

Fabrus Acquires Worldwide Rights to Chimerasome Nanocage Technology

Novavax Continues Partnership with PATH to Develop RSV Vaccine for Maternal Immunization

RBCC-n3D Assay System Utilizes Biocompatible Magnetic Nanoparticles to Print Cells Into 3D Structures

New Market Report on Functional Materials for Future Electronics

Cerulean’s CRLX101 Nanopharmaceutical Phase 2 Clinical Trial Achieves Primary Endpoint

CWRU Receives $540,000 Federal Grant to Devise Methods for Building Nanostructures

Forecast Report on Next-Generation Quantum Dot and Quantum Dot Display LED Market

Versatile Switchable Nanoparticles Detect Medical Conditions

JPK NanoTracker™ Optical Tweezers Used for Biomacromolecule Research at NTNU, Trondheim

Wyatt to Showcase Macromolecular Characterization Expertise in WCBP Seminar and Poster

News Categories

Our Latest eBook

A Closer Look at Nanoscience in 2025: A Year in Review

FeaturedArticles

Nanomedicine in 2026: Experts Predict the Year Ahead

Policy, Safety, and Regulation in the Age of Nanotechnology

Additive Nanomanufacturing: What is it and How Does it Work?

Enhancing Lipid Nanoparticle Stability for Faster Pharmaceutical Development

Turning Almond Shells into Electronics: A Conversation on Laser-Induced Graphene

Enhancing Slurry Stability in Lithium-Ion Batteries with Turbiscan Technology

Sponsored Content

The Advantages of Dynamic Light Scattering in Nanoparticle Research

In Situ Adhesion Testing Reveals More About Reliability Under Humidity Than Ex-Situ Methods

Ion Beam Cross-Sectioning and SEM Techniques for Battery Materials

Parallel Alignment Strategies for Complex Photonics Devices